Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Pair Bond
Prescribers and pharmaceutical representatives: why are we still meeting?
Optimizing Health Care Resource Allocation, Workforce "Right-Sizing," and Stakeholder Collaboration.
A highly informative microsatellite repeat polymorphism in intron 1 of the human amyloid precursor protein (APP) gene.
KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy.
See All 8 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy.
Siddiqui AD, Piperdi B. KRAS mutation in colon cancer: a marker of resistance to EGFR-I therapy. Ann Surg Oncol. 2010 Apr; 17(4):1168-76.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers, Tumor
Clinical Trials as Topic
Colonic Neoplasms
Drug Resistance, Neoplasm
ErbB Receptors
Humans
Mutation
Proto-Oncogene Proteins
Proto-Oncogene Proteins p21(ras)
ras Proteins